Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Levetiracetam Treatment of Children With Subclinical Sleep-Activated Epileptiform Activity (SSEA) - a Placebo Controlled Double-blind Cross-over-study

NCT00393614 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT00393614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00393614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Levetiracetam Treatment of Children With Subclinical Sleep-Activated Epileptiform Activity (SSEA) - a Placebo Controlled Double-blind Cross-over-study
Lead sponsor
Oslo University Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
May 31, 2007
Completion date
March 31, 2010
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

csws, subclinical sleep-activated epileptiform activity